Rivarp Medical.
LKS advises Futura Medtech on investment in Rivarp Medical: Rivarp Medical’s capabilities across orthopaedics, neurosurgery, and interventional cardiology will strengthen Futura Medtech’s positioning as a comprehensive medical devices company.
Futura Medtech, a portfolio company of Jashvik Capital, has made a strategic investment in Rivarp Medical Private Limited.
Advocate Gaurav Dayal, LKS.
Lakshmikumaran & Sridharan Attorneys advised Jashvik Capital and Futura Medtech on this transaction. The firm’s role included conducting legal due diligence on Rivarp Medical, drafting and negotiating the definitive transaction documents, and assisting with closing and completion-related matters.
The transaction team consisted of Gaurav Dayal (Executive Partner), Sushrut Biswal (Partner), Sukoon Dinodia (Senior Associate) and Chetan Soni (Associate).
The investment aligns with Jashvik Capital’s strategy of building a scaled, multi-category medical devices platform with strong domestic and global market access through Futura Medtech.
READ: Bar Council of India Probes Mamata Banerjee’s Legal Practice Status After Court Appearance
Advocate Sushrut Biswal, LKS.
Rivarp Medical’s capabilities across orthopaedics, neurosurgery, and interventional cardiology are expected to further strengthen Futura Medtech’s positioning as a comprehensive medical devices company serving diverse clinical segments.
READ: Supreme Court Clarifies Limits of High Courts’ Powers Under Article 227, Restores Compensation Award
